Connect with us

Company News

Agfa-Gevaert: Share buyback program – regulated information

Within the framework of the share buyback program which was announced in the press release of March 10, 2021, Agfa-Gevaert NV proceeded with the purchase of own shares on the market of Euronext Brussels.

The authorization to acquire own shares was granted to the Board of Directors by the Extraordinary General Meeting of Shareholders of May 12, 2020.

Agfa-Gevaert NV has requested a financial intermediary to repurchase Agfa-Gevaert shares for a maximum amount of 50,000,000 Euro on its behalf under the terms of an initial discretionary mandate agreement with validity until March 31, 2022, effective as from April 1, 2021.

As a result of a decision of the Board of Directors, the company, by notarial deed dated December 28, 2021, cancelled a total of 2,288,302 treasury shares. This decision was taken in accordance with the authorization granted to the Board of Directors by the Extraordinary General Meeting of Shareholders on May 12, 2020. As a consequence, the new number of outstanding shares (denominator) is 160,506,706.

On February 4, 2022, the Agfa-Gevaert Group held 939,027 own shares, which represents 0.59% of the total number of shares of the Group.

Since the beginning of the share buyback program until February 4th, 2022; the Agfa-Gevaert Group bought 8,183,511 own shares, representing 4.88% of the total outstanding shares on April 1, 2021.
MB Bureau

Copyright © 2024 Medical Buyer

error: Content is protected !!